US Stock MarketDetailed Quotes

DXCM DexCom

Watchlist
  • 80.040
  • +4.220+5.57%
Close Dec 20 16:00 ET
  • 80.040
  • 0.0000.00%
Post 20:01 ET
31.26BMarket Cap48.51P/E (TTM)

DexCom Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DexCom Q3 2024 Earnings Date

Currency：USDOct 24, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
991.19M
994.20M
+3.01M
Beat Est.
+1.66%
+1.97%
+0.30%
EPS
0.41
0.34
-0.07
Miss Est.
+41.79%
+17.24%
-17.32%
Analyst Rating
Strong Buy

Dec 17, 2024

DexCom Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.030B--
--2024/Q4-- / 1.096B--
Oct 24, 20242024/Q3994.200M / 991.187M--
Jul 25, 20242024/Q21.004B / 1.037B--
--2024/Q1921.000M / 910.902M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.030B--
--2024/Q4-- / 1.096B--
Oct 24, 20242024/Q3994.200M / 991.187M--
Jul 25, 20242024/Q21.004B / 1.037B--
--2024/Q1921.000M / 910.902M--

Unlock Free Earnings Estimates

DexCom Earnings Reports

  • DexCom | 10-Q: Q3 2024 Earnings Report

    Oct 24 17:14 ET

  • DexCom | 8-K: Dexcom Reports Third Quarter 2024 Financial Results

    Oct 24 16:10 ET

  • DexCom | 10-Q: Q2 2024 Earnings Report

    Jul 25 17:19 ET

  • DexCom | 8-K: Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program

    Jul 25 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 17, 2024

    Strong Buy

    • Buy

      82.35%

    • Hold

      17.65%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Internet of Things
    Internet of Things
    Intraday+2.05%